Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Marta Wosinska"'
Autor:
Nathan Miller, Steven Berry, Fiona Scott Morton, Jonathan Baker, Timothy Bresnahan, Martin Gaynor, Richard Gilbert, George Hay, Ginger Jin, Bruce Kobayashi, Francine Lafontaine, James Levinsohn, Leslie Marx, John Mayo, Aviv Nevo, Ariel Pakes, Nancy Rose, Daniel Rubinfeld, Steven Salop, Marius Schwartz, Katja Seim, Carl Shapiro, Howard Shelanski, David Sibley, Andrew Sweeting, Marta Wosinska
Publikováno v:
Journal of Antitrust Enforcement. 10:248-259
The article explains why regressions of price on HHI should not be used in merger review. Both price and HHI are equilibrium outcomes determined by demand, supply, and the factors that drive them. Thus, a regression of price on the HHI does not recov
Autor:
Marta Wosinska, Kirk W. Kerr
Publikováno v:
Therapeutic Innovation & Regulatory Science. 51:16-23
The isotretinoin risk management program iPLEDGE places requirements on patients and providers to ensure that the benefits of isotretinoin therapy outweigh the risks. Such burdens have the possibility of limiting patient access through mechanisms suc
Autor:
Marta Wosinska, William Liu
Publikováno v:
Therapeutic innovationregulatory science. 51(4)
Contract manufacturing of prescription drugs is perceived to be on the rise, as companies look to optimize manufacturing capacity by either outsourcing or manufacturing for others. The lack of transparency into these proprietary arrangements has led
Autor:
Samuel H. Kina, Marta Wosinska
Publikováno v:
Handbook of Pricing Research in Marketing. :488-511
Autor:
Marta Wosinska, Ying Xie, Paris Cleanthous, Jaap E. Wieringa, Andrew T. Ching, Sridhar Narayanan, Xiaojing Dong, Thomas J. Steenburgh, Sanjog Misra, Peter S.H. Leeflang, Dick R. Wittink, Natalie Mizik, Min Ding, Puneet Manchanda
Publikováno v:
Marketing Letters, 16(3-4), 293-308. SPRINGER
This paper argues that the pharmaceutical industry represents an exciting opportunity to carry out academic research. The nature of the industry allows researchers to answer new questions, develop new methodologies for answering these questions as we
Autor:
Marta Wosinska
Publikováno v:
Journal of Marketing Research. 42:323-332
Because of their arm's-length relationship with patients, pharmaceutical manufacturers have been interested in whether drug advertising can improve therapy compliance. Contrary to many industry surveys, the author finds that the impact is small in ec
Publikováno v:
Journal of Corporate Finance. 10:527-548
In a sample of California hospitals, we find that the composition of the board of directors varies systematically across ownership types. For all ownership types, except government-owned, we find that poor financial performance is related to board an
Autor:
Marta Wosinska, Robert S. Huckman
Publikováno v:
Health Affairs. 23:W4-409
Mail-order pharmacies have lower aggregate generic-dispensing rates than their retail counterparts. This fact has been used as evidence of self-dealing that could arise when a pharmacy be...
Autor:
Janet Woodcock, Marta Wosinska
Publikováno v:
Clinical Pharmacology & Therapeutics.
Over the past few years, an increasing number of critically needed medicines have been in short supply. Using economic theory to frame the drug-shortage problem, this paper explores why and how manufacturing-quality problems could combine with other
Autor:
Marta Wosinska
Publikováno v:
SSRN Electronic Journal.
Three out of four patients who ask a physician for a drug get it prescribed. Do patients really wield so much influence? Empirical analysis of patient-level prescription claims reveals that direct-to-consumer advertising does impact the choice probab